Patent · US Active

Pyrrolobenzodiazepines and targeted conjugates

US9713647B2 · kind B2 · utility

21Cited by

51References

10Claims

0Family size

Assignees

SEATTLE GENETICS, INC. · US
MedImmune Limited · US

Inventors

Scott Jeffrey · Bothell, US
Patrick Burke · Bothell, US
Philip Wilson Howard · London, GB

Key dates

Filing date	Jun 14, 2016
Grant date	Jul 25, 2017
Priority date	—
Expiry date	Jun 14, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound, or a pharmaceutically acceptable salt or solvate thereof, or conjugates thereof, selected from the group consisting of:wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.